CUBT
Curative Biotechnology Inc
NYSE MKT: CUBT · HEALTHCARE · BIOTECHNOLOGY
$0.94
+0.00% today
Updated 2026-04-29
Market cap
$1.07B
P/E ratio
—
P/S ratio
158.53x
EPS (TTM)
$-0.72
Dividend yield
—
52W range
$0 – $1
Volume
0.1M
Curative Biotechnology Inc (CUBT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-399588.00 | $-142213.00 | $-35679.00 | $-20992.00 | $1955.00 | $-5891.00 | $-150.00 | $-150.00 | $-150.00 | $-190093.00 | $-1.60M | $-1.54M | $-486585.00 | $-1.02M |
| Capital expenditures | $1846.00 | $4689.00 | $42871.00 | $6834.00 | $0.00 | $0.00 | $0.00 | $0.00 | $6834.00 | $34300.00 | $21334.00 | $76905.00 | $14041.00 | $1.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | — | — | $4.30M | $2.89M | $278804.00 | $228293.00 | — |
| Free cash flow | $-401434.00 | $-146902.00 | $-78550.00 | $-27826.00 | $1955.00 | $-5891.00 | $-150.00 | $-150.00 | $-6984.00 | $-224393.00 | $-1.63M | $-1.61M | $-500626.00 | $-1.02M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |